InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Filip Janku. Officer active across 2 companies, notably Monte Rosa Therapeutics, Inc.. Aggregated, 4 reports have been recorded. Activity tracked since 23 June 2026. The latest transaction was filed on 30 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations